TY  - CHAP
M1  - Book, Section
TI  - Chapter 110. Dyslipoproteinemia
A1  - Katzel, Leslie I.
A1  - Blumenthal, Jacob
A1  - Sorkin, John D.
A1  - Goldberg, Andrew P.
A2  - Halter, Jeffrey B.
A2  - Ouslander, Joseph G.
A2  - Tinetti, Mary E.
A2  - Studenski, Stephanie
A2  - High, Kevin P.
A2  - Asthana, Sanjay
PY  - 2009
T2  - Hazzard's Geriatric Medicine and Gerontology, 6e
AB  - Dyslipoproteinemia,  also  referred  to  as  dyslipidemia,  encompasses  a  range  of  disorders  of  lipoprotein  lipid  metabolism  that  include  both  abnormally  high  and  low  lipoprotein  concentrations,  as  well  as  abnormalities  in  the  composition  of  these  lipoprotein  particles.  Dyslipoproteinemias  are  clinically  important  because  of  their  role  in  the  pathogenesis  of  cardiovascular  disease  (CVD),  which  includes  coronary  artery  disease  (CAD),  cerebrovascular  disease,  peripheral  vascular  disease,  and  renal  disease.  Thus  the  term  dyslipoproteinemia  is  broader  than  the  term  hyperlipidemia,  which  focuses  solely  on  the  concentrations  of  the  lipoproteins.  
SN  - 
PB  - The McGraw-Hill Companies
CY  - New York, NY
Y2  - 2022/05/20
UR  - accessmedicine.mhmedical.com/content.aspx?aid=5133518
ER  -